Novel use of lycopene
OwnerLuca Barella, Regina Goralczyk +2inventors
InventorsLuca Barella, Regina Goralczyk, Ulrich Siler, Karin Wertz
Life of this patent
Estimating the term…
Abstract
Lycopene can be used in the primary prevention and incidence risk reduction of non-cancerous symptoms and/or pathologies (i.e., the prophylactic supplementation of the healthy subjects), in the treatment or the coadjuvant treatment of non-can-cerous symptoms and/or pathologies (i.e. the supplementation as therapy or accompanying a running therapy) and in the secondary prevention of non-cancerous symptoms and/or pahtologies (i.e., the supplementation after a successful therapy for the prevention of the relapse), which are associated with, favored by or caused by androgen signalling or which are sensitive to a reduction of androgen signalling.
Claims31
A method of manufacture of a composition for the primary and secondary prevention, incidence risk reduction, coadjuvant treatment or treatment of non-cancerous symptoms and/or pathologies, which are associated with, favored by or caused by androgen signalling, or which are sensitive to a reduction of androgen signalling comprising admixing an effective amount lycopene with a conventional carrier material.
A method of prevention or treatment of symptoms or pathologies associated with androgen signalling, which comprises administering to a subject (mammal or non-mammal, human or pet including birds and fish, or mammal or non-mammal farm animal) in need of such treatment for therapy or prophylaxis an effective amount of lycopene.
A method of treating non-cancerous symptoms and/or pathologies sensitive to lycopene which comprises administering to a mammal, mammal or non-mammal pets including birds and fish, or mammal or non-mammal farm animal in need of such treatment an amount of lycopene which leads to a reduction of androgen signalling.
Dependencies are inferred from the claim text.